Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
It's about real people, real health, and the future of obesity treatment
While GLP-1 medications offer significant benefits for many patients with type 2 diabetes, it's essential to recognize and address their limitations and downsides
Semaglutide, a GLP-1 receptor agonist, has demonstrated strong global outcomes in improving glycaemic control and aiding weight management
May your providers stay legitimate, your dosing stay accurate, and your results stay consistent.
10.1172/jci.insight.93382 Summary Keywords glucagon-like peptide-1 receptor agonists, ocular diseases, glaucoma, diabetic retinopathy, mechanism Citation Xie Z, Yang Z, Tian D and Chen Y (2025) Unlocking the potential of GLP-1 receptor agonists in ocular therapeutics: from molecular pathways to clinical impact
